The Myeloma Minutes

Introduction to The Myeloma Minutes podcast series

Comprehensive overview of myeloma and common patient questions

Introduction to the healthcare team and their roles in myeloma care

Deep dive into steroid treatments, their benefits and side effects

Understanding clinical trials and research participation

Patient story about managing steroid treatments and side effects

Understanding smouldering myeloma and monitoring approaches

Expert discussion on imaging and scans in myeloma diagnosis

Understanding bone health and bisphosphonate treatments

Guide to initial myeloma diagnosis and early care steps

Comprehensive guide to induction therapy options and approaches

Treatment options for patients who are not transplant candidates

Innovative new treatment approach and NHS implementation

Understanding stem cells and the collection process

Understanding the transplant process from preparation to recovery

This episode explores what happens after a stem cell transplant in multiple myeloma.

Specialist nurse Alex Scott walks patients and carers through every step of the autologous stem cell transplant process.

This episode explores bispecific antibodies — how they work, the benefits they bring, and the key side effects patients and carers need to know about.

This episode explains the newly approved four-drug treatment (Isatuximab, Velcade, Lenalidomide and Dexamethasone) for older people with myeloma who are not eligible for a stem cell transplant.

This episode features Dr Sophie Castell, CEO of Myeloma UK, sharing insights into the charity's vital work in research, advocacy, patient support, and tackling inequalities in myeloma care.

This episode unpacks the complex world of myeloma genetics with Sarah Gooding, an Honorary Consultant Haematologist, based in Oxford.

Dr Jam & Dr Sally unpack what remission, relapse and refractory disease truly mean for people living with myeloma, and explore how close we are to talking about cure.

Drs Jam & Sally unpack what neuropathy is, why it happens in myeloma treatment, and how patients can recognise, prevent and manage it to protect their quality of life.

Sean Molloy, renown spinal surgeon at the Royal National Orthopaedic Hospital (RNOH) NHS Trust in Stanmore explains how tailored bracing, breakthrough bone healing in myeloma, physiotherapy and minimally invasive vertebroplasty can transform pain, mobility and long-term spinal stability.

This episode introduces Talquetamab - a newly approved bispecific antibody for relapsed myeloma - explaining how it works, who it's for, and what side effects patients should expect and prepare for.

Dr Jam Katari and Dr Sally Moore are joined by leading myeloma experts to look back on 2025's biggest breakthroughs; from early treatment for smouldering myeloma to cutting-edge CAR-T therapy made inside the body.

Dr Jam Katari and Dr Sally Moore are joined by leading myeloma experts to look back on 2025’s biggest breakthroughs; from functional cures and new treatments to patient-friendly innovations.

This episode looks ahead to 2026, exploring upcoming myeloma treatments, major research advances, and the topics patients and carers most want to understand.

This episode explains the new NICE-approved combination of belantamab, pomalidomide and dexamethasone for people whose myeloma has relapsed after first-line treatment, including benefits, side effects and how treatment decisions are made.

In this episode Doctors Jam & Sally explain CAR-T cell therapy for myeloma - how it works, what the treatment journey looks like, the potential side effects, and why it offers hope for longer treatment-free time.